organ transplant
The 2020 spinout from UK firm Renalytix is launching an acute rejection risk test, with two other transplant tests expected to launch within the next two years.
Omixon Picks up Option to Acquire Organ Monitoring Group
The option comes as part of an alliance between the companies to codevelop an organ transplant monitoring assay.
Oncocyte Q1 Revenues Rise 27 Percent on DetermaRx Activity
The Irvine, California-based diagnostics firm reported $1.4 million in revenue, missing the consensus Wall Street estimate of $2.2 million.
Hologic Nabs FDA Approval for Quantitative Cytomegalovirus Test
The test runs on Hologic's Panther system and is intended to be used for post-transplant pathogen detection and monitoring.
Three new studies focusing on the heart, lungs, and kidneys add to a growing body of evidence in support of donor-derived cell-free DNA as an organ health measure.